ERIE, Pa., Oct. 12, 2020 /PRNewswire/ — Whether shopping for electronics, furniture or a new car, we all love getting the most bang for our buck – and insurance companies know drivers are looking for bargains when it comes to their car insurance. That’s why many insurers advertise low monthly rates to convince customers they’re getting a great deal. But in the event of an accident, that super-cheap auto insurance might leave you stuck paying out of pocket for car repairs or medical bills.
Erie Insurance helps sort it out with a four ways cheap auto policies often fall short, and nine ways to save on your premium without compromising your coverage.
What are the downsides?
You could pay more out of pocket later. When you’re found at-fault for an accident, you’re on the hook to pay for anything your insurance policy doesn’t cover. The cost of repairs, medical bills or legal fees from a multi-car pileup can get expensive. Even something simple like a fender bender can cost thousands of dollars in parts alone.
You take on more risk. If you run out of cash to pay what you’re responsible for, that could put your savings, investments or assets like your home or car at risk.
You get fewer perks. You typically pay a little extra in premium for features like rental car expense coverage, emergency roadside service coverage or a diminishing deductible. But you’ll be happy to have those little extras there when you need them.
It’s less personalized. A good insurance agent can help tailor your policy with endorsements and other optional add-ons to be just the right fit for your life. For example, customized coverage can come in handy when you drive occasionally for Uber or Lyft.
We have been watching the trading trends on Red Rock Resorts, Inc. (RRR) for some time. As of late, there appears to be growing bullish sentiment on the stock related to its 2Q20 performance. Like the entire gaming sector, it has been pandemic battered. But analysts believed the revenue profile of the quarter beat expectations of a lesser decline than forecast. This they reasoned, was a buy signal for the stock which has been trading ~$17 a share. Those results to us are not dazzling enough alone to warrant a move on the shares. But there are deeper rationales we see spread over a longer time frame that give us conviction that RRR may now be at an attractive entry point.
As with all gaming stocks, we always begin with management culture and DNA. On that level, RRR stands with its Vegas locals competitors in executing a strong customer service culture dating back to its earlier life when it was Station Casinos. That is directly linked to the Fertitta family which founded and still controls a significant chunk of the equity.
(Biographical note: The Vegas Fertittas are distant cousins of Tilman Fertitta, swashbuckling Texas entrepreneur who runs Golden Nugget (GN), Landry’s Restaurants (LNY) and the Houston Rockets NBA team. Tilman and his family are prominent members of Houston’s business and philanthropic communities as are their Vegas cousins.)
Tilman made an exchange of stock run at Caesars (NASDAQ:CZR) last year that quickly faded at Eldorado Resorts (ERI) when Carl Icahn entered the fray. This gave rise to speculation among the chattering classes of Vegas that a possibility of a merger between the cousins could loom at some point going forward. I don’t put high percentage odds on that at the moment but
In our previous analysis, we discussed one primary reason that Bitcoin will make a good long-term investment as the price is likely to go up and stabilize once institutions gain SEC-regulated access. Fidelity and the NYSE-founded Bakkt are two examples of platforms that will influence the first phase of bitcoin’s broader adoption. These two platforms have not yet launched, but a new supply-and-demand dynamic will occur when institutional investors can access cryptocurrencies.
The next phase for Bitcoin stability and price support will hinge on the eroding trust in fiat currencies – both globally and also from younger generations who are digital natives with good reason to seek alternatives outside of the fiat system.
Global Unrest Sees Bitcoin as Alternative to Fiat Currency
Economists have discussed the effects of going off the gold standard during Nixon’s presidency ad nauseum, yet this has been a futile conversation in the past as there has been no alternate method of transacting other than centralized cash. Gold and precious metals are hard to transport and cannot be used to transact daily in the modern age, despite having a store of value.
Globally, bitcoin is more attractive than many foreign currencies. Venezuela, for instance, is going through a period of hyperinflation with a cup of coffee costing 2,800 bolivars up from 0.75 bolivars less than a year ago, representing an increase of 373,233%, according to Bloomberg data. Essential goods such as toilet paper and medicine are very expensive, and many Venezuelans are fleeing the country.
Bitcoin has emerged as a solid alternative to Venezuelan bolivars. Even when Bitcoin loses value from $19,000 to $3,000, it’s still outperforming the inflation of Venezuela’s currency. On the flip side, when Bitcoin rises in value from $5,000 to $11,000 in one month, it allows global populations to hold an appreciating
Rhythm Pharmaceuticals, Inc. RYTM was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is down 16.5% in the past one-month time frame.
The company has seen no estimate revision in the past month, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Rhythm Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Rhythm Pharmaceuticals, Inc. Price
Rhythm Pharmaceuticals, Inc. price | Rhythm Pharmaceuticals, Inc. Quote
A better-ranked stock in the Medical – Biomedical and Genetics industry is Emergent BioSolutions Inc. EBS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.3% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Click to get this free report
Emergent Biosolutions Inc. (EBS): Free Stock Analysis Report
Rhythm Pharmaceuticals, Inc. (RYTM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The past three months (to say nothing about this year in general) in the stock market have felt distinctly like a roller coaster ride. First climbing upward rapidly from July until early September, then abruptly sliding downward until late September, then bottoming out and angling upward again. Market participants are being pulled and jerked around in their restraints as they hang onto the handles.
The relative lack of volatility from mid-2016 through late 2018 and from early 2019 through February, 2020 felt like a pleasant horse-drawn carriage ride compared to the Covid era.
This has been even truer of many dividend stocks this year, as the risk of dividend cuts has induced yield-starved investors to vacillate wildly between fear and greed. It really is reminiscent of the speedy swings of emotion one feels on a roller coaster ride: anticipation and reward, excitement and terror, exhilaration and panic, laughing and shrieking.
So much happens in seemingly so little time.
And then, when it’s over, you’re left thinking, “We waited an hour and a half for a 60 second ride?“
One benefit of being a dividend-focused investor is that stock market volatility, while anxiety-inducing, matters less — as long as one remains confident in the safety of one’s dividend income stream. We at High Yield Landlord try to put emotions aside and invest like landlords, paying less attention to asset prices and more to the operations of the business and the stability of cash inflows.
With that in mind, let’s take a look at five dividend growth stocks that remain good buys even as the market has enjoyed an October rebound.
1. Gilead Sciences (GILD)
Admittedly, biopharmaceutical company Gilead Sciences, which invented the drug that treats most HIV patients,